Adicet Bio Inc (ACET)
1.875
-0.22
(-10.71%)
USD |
NASDAQ |
Apr 24, 16:00
1.875
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Enterprise Value: -5.672M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | -5.672M |
| April 23, 2024 | 12.81M |
| April 22, 2024 | 4.597M |
| April 19, 2024 | 0.4893M |
| April 18, 2024 | 6.651M |
| April 17, 2024 | 26.78M |
| April 16, 2024 | 20.21M |
| April 15, 2024 | 21.03M |
| April 12, 2024 | 17.74M |
| April 11, 2024 | 24.31M |
| April 10, 2024 | 16.92M |
| April 09, 2024 | 28.42M |
| April 08, 2024 | 19.38M |
| April 05, 2024 | 25.14M |
| April 04, 2024 | 27.60M |
| April 03, 2024 | 25.96M |
| April 02, 2024 | 34.17M |
| April 01, 2024 | 37.46M |
| March 28, 2024 | 33.35M |
| March 27, 2024 | 31.71M |
| March 26, 2024 | 24.31M |
| March 25, 2024 | 21.03M |
| March 22, 2024 | 20.21M |
| March 21, 2024 | 7.883M |
| March 20, 2024 | 16.10M |
| Date | Value |
|---|---|
| March 19, 2024 | 7.062M |
| March 18, 2024 | 0.4893M |
| March 15, 2024 | 4.597M |
| March 14, 2024 | 8.705M |
| March 13, 2024 | 24.90M |
| March 12, 2024 | 33.93M |
| March 11, 2024 | 42.13M |
| March 08, 2024 | 39.67M |
| March 07, 2024 | 36.39M |
| March 06, 2024 | 37.21M |
| March 05, 2024 | 30.65M |
| March 04, 2024 | 35.57M |
| March 01, 2024 | 37.21M |
| February 29, 2024 | 33.11M |
| February 28, 2024 | 31.47M |
| February 27, 2024 | 36.39M |
| February 26, 2024 | 38.85M |
| February 23, 2024 | 42.95M |
| February 22, 2024 | 40.49M |
| February 21, 2024 | 61.00M |
| February 20, 2024 | 74.13M |
| February 16, 2024 | 81.52M |
| February 15, 2024 | 86.44M |
| February 14, 2024 | 78.24M |
| February 13, 2024 | 67.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-146.46M
Minimum
Sep 29 2023
628.77M
Maximum
Nov 11 2022
141.97M
Average
118.93M
Median
Jun 30 2021
Enterprise Value Benchmarks
| Sagimet Biosciences Inc | 38.18M |
| Catalyst Pharmaceuticals Inc | 1.644B |
| Codexis Inc | 131.73M |
| Annexon Inc | 140.90M |
| Inhibrx Inc | 1.558B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.49M |
| Total Expenses (Quarterly) | 31.57M |
| EPS Diluted (Quarterly) | -0.68 |
| Earnings Yield | -176.5% |
| Normalized Earnings Yield | -61.33 |